BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Association of Pulmonary Advanced Practice Providers (APAPP) - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pulmapp.com
X-WR-CALDESC:Events for Association of Pulmonary Advanced Practice Providers (APAPP)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20270314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20271107T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20251014T170000
DTEND;TZID=America/Chicago:20251014T203000
DTSTAMP:20260406T054958
CREATED:20251006T204613Z
LAST-MODIFIED:20251006T205320Z
UID:18414-1760461200-1760473800@www.pulmapp.com
SUMMARY:APAPP Regional Meeting Series: Dallas\, TX
DESCRIPTION:Dallas\, TX- Join us on Tuesday\, October 14\, 2025\, for our third APAPP Regional Series Session!  \nThis session will be at the Marriott Dallas Las Colinas\, 5- 8:30 PM with Barb Chamness\, MSN\, APRN\, FNP-C\, and Sarah Tomashefski\, MSN\, AGNP-C \nEach regional meeting provides a comprehensive\, guideline-based review of key pulmonary conditions\, including: \n\nInterstitial Lung Disease (ILD)\nChronic Obstructive Pulmonary Disease (COPD)\nAsthma\nPulmonary Hypertension in ILD (PH-ILD)\nObstructive Sleep Apnea (OSA)\n\nOur curriculum is tailored to meet APPs at their current knowledge level\, featuring the latest emerging data and therapeutic updates. We’ll focus on the practical application of evolving evidence to help you provide the best possible care to your patients. \nDon’t miss out on this opportunity to earn credits!  \nYou can earn AAPA\, ANCC\, and ACPE credits and/or contact hours by attending this series. It’s the perfect opportunity to expand your knowledge\, connect with peers\, and stay on top of the latest advancements in pulmonary medicine. \nREGISTER FOR FREE.  \n\nFuture sessions include:\n\n\nNew York\, NY – Wednesday\, November 5\, 2025\n\n\nTampa\, FL – Wednesday\, November 12\, 2025\n\n\nLos Angeles\, CA – Wednesday\, November 13\, 2025
URL:https://www.pulmapp.com/event/apapp-regional-meeting-series-dallas-tx/
LOCATION:Marriott Dallas Las Colinas\, 223 W Las Colinas Blvd\, Irving\, TX\, 75039\, United States
CATEGORIES:Asthma,COPD,ILD,Pulmonary Hypertension
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2025/10/FMC-25-31-APAPP-Regional-Conference_Social-Media_Instagram_TX_v6-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251019
DTEND;VALUE=DATE:20251023
DTSTAMP:20260406T054958
CREATED:20250217T181423Z
LAST-MODIFIED:20251006T175929Z
UID:17454-1760832000-1761177599@www.pulmapp.com
SUMMARY:CHEST 2025 in Chicago
DESCRIPTION:CHEST 2025 will bring you the most up-to-date education in clinical pulmonary\, critical care\, and sleep medicine with world-class speakers\, hands-on simulation opportunities\, interactive educational games\, and so much more. \n\n\n\nAPAPP at CHEST 2025 (2)\n\n\n\n\n\nLEARN MORE ABOUT CHEST 2025 HERE. 
URL:https://www.pulmapp.com/event/chest-2025-in-chicago/
LOCATION:Chicago\, IL
CATEGORIES:Allergies,Asthma,Bronchology,COPD,Critical Care,Expo,ILD,Interventional Pulmonology,PAH,Pulmonary Hypertension
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2025/02/Screenshot-2025-02-17-110727.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251105T170000
DTEND;TZID=America/New_York:20251105T203000
DTSTAMP:20260406T054958
CREATED:20251006T205249Z
LAST-MODIFIED:20251006T205935Z
UID:18417-1762362000-1762374600@www.pulmapp.com
SUMMARY:APAPP Regional Meeting Series: New York City
DESCRIPTION:New York City\, NY-  Join us on Tuesday\, Wednesday\, November 5\, 2025\, for our fourth APAPP Regional Series Session!  \nThis session will be at the Westin New York at Times Square\, 5- 8:30 PM with Alanna Kavanaugh\, EdD(c)\, FNP-BC\, MSN\, BSN\, CCRN\, and Sarah Tomashefski\, MSN\, AGNP-C \nEach regional meeting provides a comprehensive\, guideline-based review of key pulmonary conditions\, including: \n\nInterstitial Lung Disease (ILD)\nChronic Obstructive Pulmonary Disease (COPD)\nAsthma\nPulmonary Hypertension in ILD (PH-ILD)\nObstructive Sleep Apnea (OSA)\n\nOur curriculum is tailored to meet APPs at their current knowledge level\, featuring the latest emerging data and therapeutic updates. We’ll focus on the practical application of evolving evidence to help you provide the best possible care to your patients. \nDon’t miss out on this opportunity to earn credits!  \nYou can earn AAPA\, ANCC\, and ACPE credits and/or contact hours by attending this series. It’s the perfect opportunity to expand your knowledge\, connect with peers\, and stay on top of the latest advancements in pulmonary medicine. \nREGISTER FOR FREE.  \n\nFuture sessions include:\n\n\nTampa\, FL – Wednesday\, November 12\, 2025\n\n\nLos Angeles\, CA – Wednesday\, November 13\, 2025
URL:https://www.pulmapp.com/event/apapp-regional-meeting-series-new-york-city/
LOCATION:Westin New York at Times Square\, 270 W 43rd St\, New York\, NY\, 10036\, United States
CATEGORIES:Asthma,COPD,Free CME,ILD,Pulmonary Hypertension
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2025/10/FMC-25-31-APAPP-Regional-Conference_Social-Media_Instagram_NY_v7-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251108T090000
DTEND;TZID=America/New_York:20251108T150000
DTSTAMP:20260406T054958
CREATED:20251021T222122Z
LAST-MODIFIED:20251021T222122Z
UID:18505-1762592400-1762614000@www.pulmapp.com
SUMMARY:Conversations in Pulmonology: 2025 - Live Virtual Conference on November 8\, 2025
DESCRIPTION:Join us online from the comfort and safety of your home or office! \nRegistration Fee\nThere is no registration fee for this activity. \nSpecial Accommodations\nNACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need. \nProgram Summary\nJoin Fernando J. Martinez\, MD and Corinne R. Young\, MSN\, FNP-C\, FCCP and stay on track to fulfill your CME requirements from the comfort of your home. Utilizing an interactive\, moderator-led format\, this program will present discussions with national thought leaders to help you hone your skills in the diagnosis and management of patients you are likely to encounter in your practice. You will be able to interact with the faculty in real-time to get your questions answered. The presentations will include several interactive cases and discussion sessions to keep you actively learning. \nFeatured Sessions \nEvolving Strategies in ILD: Detection\, Diagnosis\, and Disease-Specific Management \n\nDiscuss the newly-defined radiographic finding if ILAs and their implications in lung disease management\nReview the diagnostic criteria for ILD\nIndividualize the management of SSc-ILD based on guidelines and patient presentation\n\nPAH at Follow-up – For the Patients Who Don’t Achieve Low Risk \n\nReview the diagnostic workup for patients with suspected PAH\nDiscuss initial therapy in PAH\, including selecting patients for newer fixed-dose combination therapy\nIncorporate guideline- and evidenced-based approaches to adjusting therapies in patients with PAH not achieving low-risk status\nReview the landscape of emerging agents for PAH\, noting mechanistic targets and available clinical data\n\nAdvancing COPD Care: Applying Latest Guidance in Clinical Practice \n\nReview the relationship between inflammation\, exacerbation\, and disease progression in COPD noting the underlying pathophysiology\nDiscuss recent evidence surrounding the use of biologic agents in the management of patients with COPD\, including patient populations and outcomes\nIntegrate the use of biologic agents into the management of patients with COPD based on guidelines and clinical evidence for new and emerging agents\n\nAgenda* \n9:00 – 9:05 am ET\nWelcome Remarks\nFernando Martinez\, MD\, MS and Corinne Young\, MSN\, FNP-C\, FCCP \n9:05 – 10:05 am\nEvolving Strategies in ILD: Detection\, Diagnosis\, and Disease-Specific Management\nFaculty: Corinne Young\, MSN\, FNP-C\, FCCP\nModerator: Fernando Martinez\, MD\, MS \n10:05 – 10:20 am\nBreak \n10:20 – 11:20 am\nPresentation Theater**: Triple Therapy in Focus; The importance of a Proactive Approach\n(CME not offered) \n11:20 – 11:30 am\nBreak \n11:30 am – 12:35 pm\nPAH at Follow-up – For the Patients Who Don’t Achieve Low Risk\nFaculty: Ioana R Preston\, MD\nModerator: Corinne Young\, MSN\, FNP-C\, FCCP \n12:35 – 12:50 pm\nBreak \n12:50 – 1:50 pm\nPresentation Theater**: New Pathways in Immunoscience—Respiratory Disease and Beyond\n(CME not offered) \n1:50 – 2:00 pm\nBreak \n2:00 – 3:00 pm\nAdvancing COPD Care: Applying Latest Guidance in Clinical Practice\nFaculty: Fernando J. Martinez\, MD\, MS\nModerator: Corinne Young\, MSN\, FNP-C\, FCCP \n3:00 pm\nClosing Remarks \n* Subject to change \n** A separate URL will be used for all presentation theaters. Participants are required to exit the educational session and enter the presentation theater with the separate URL provided. \nFaculty and Moderators\nFernando Martinez\, MD\, MS\nVice-Chair\, Clinical and Translational Research\nAcademic Chief\, Pulmonary\, Allergy\, and Critical Care Medicine\nUMass Chan Medical School\nWorcester\, MA \nCorinne R. Young\, MSN\, FNP-C\, FCCP\nPresident\, Association of Pulmonary Advanced Practice Providers\nDirector of APP and Clinical Services\nColorado Springs Pulmonary Consultants\nColorado Springs\, CO\n \nNurse Planner and Peer Reviewer\nMarjorie Crabtree\, DNP\, FNP\, ANP\nHaymarket Medical Education\nSteering Committee\nNurse Practitioner Healthcare Foundation\nAccredited Provider Program Director\nBellevue\, WA \nBernadette Makar\, MSN\, NP\nSaint Peter’s University Hospital\nCoordinator House Service Program\nNew Brunswick\, NJ\nRutgers University\nClinical Adjunct\nNewark\, NJ \nProvided By\nThe National Association for Continuing Education in partnership with the Association for Pulmonary Advanced Practice Providers (APAPP). \n \nNACE Accreditation Statement\nThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. \nNACE Credit Designation Statement\nThe National Association for Continuing Education designates this live activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nNACE AANP Provider\nThe National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 3.0 contact hours (which may include hours of pharmacology). \n\nPolicy on Faculty and Provider Disclosure\nAccredited education provided by the National Association for Continuing Education (NACE) must demonstrate balance\, independence\, objectivity\, and scientific rigor. All individuals in a position to influence the content of NACE accredited education are required to disclose all financial relationships with ineligible companies within the previous 24-month period\, regardless of relevance to the education. All relevant financial relationships and potential conflicts of interest will be mitigated prior to the activity. \nThe ACCME defines ineligible companies as those whose primary business is producing\, marketing\, selling\, re-selling\, or distributing healthcare products used by or on patients. \nCommercial Support\nThis program is supported by an educational grant from Johnson & Johnson\, an independent educational grant from Regeneron Pharmaceuticals\, Inc and Sanofi and by an independent medical education grant from GSK. \nRegister today!
URL:https://www.pulmapp.com/event/conversations-in-pulmonology-2025-live-virtual-conference-on-november-8-2025/
LOCATION:Virtual
CATEGORIES:COPD,Free CME,ILD,PAH,Virtual
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2025/10/CIP-11.8.25-Event-Banner-552x289-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251110T120000
DTEND;TZID=America/Los_Angeles:20251110T140000
DTSTAMP:20260406T054958
CREATED:20251029T181448Z
LAST-MODIFIED:20251029T181448Z
UID:18524-1762776000-1762783200@www.pulmapp.com
SUMMARY:A Systematic Approach for Management of Patients With COPD and Alpha1-Antitrypsin Deficiency with Brian Bizik\, PA
DESCRIPTION:Uncover Alpha-1 \nNovember Awareness Month \nYou are invited to: A Systematic Approach for Management of Patients With COPD and Alpha1-Antitrypsin Deficiency \nJoin us to learn about: \n• Alpha-1 Antitrypsin Deficiency (AATD)\n• Ruling out AATD as part of COPD care\n• Systematic screening for AATD and Interpreting test results\n• Managing AATD patients \nPresented by: Brian Bizik\, MS\,PA\nHosted by: Sophia Robertson-Lavalle  \nMonday\, November 10\, 2025 – 12:00PM – Pacific Standard Time \n\nVirtual Takeda Location\n650 E Kendall St\nCambridge\, Massachusetts 02142
URL:https://www.pulmapp.com/event/a-systematic-approach-for-management-of-patients-with-copd-and-alpha1-antitrypsin-deficiency-with-brian-bizik-pa/
LOCATION:Virtual Takeda Location
CATEGORIES:COPD,Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251112T170000
DTEND;TZID=America/New_York:20251112T203000
DTSTAMP:20260406T054958
CREATED:20251006T205848Z
LAST-MODIFIED:20251006T205848Z
UID:18420-1762966800-1762979400@www.pulmapp.com
SUMMARY:APAPP Regional Meeting Series: Tampa\, FL
DESCRIPTION:Tampa\, FL – Join us on Tuesday\, November 12\, 2025\, for our fifth APAPP Regional Series Session!  \nThis session will be at the Grand Hyatt Tampa Bay\, 5- 8:30 PM with Beth Albert\, PPCNP\, and Tish Haight\, APRN. \nEach regional meeting provides a comprehensive\, guideline-based review of key pulmonary conditions\, including: \n\nInterstitial Lung Disease (ILD)\nChronic Obstructive Pulmonary Disease (COPD)\nAsthma\nPulmonary Hypertension in ILD (PH-ILD)\nObstructive Sleep Apnea (OSA)\n\nOur curriculum is tailored to meet APPs at their current knowledge level\, featuring the latest emerging data and therapeutic updates. We’ll focus on the practical application of evolving evidence to help you provide the best possible care to your patients. \nDon’t miss out on this opportunity to earn credits!  \nYou can earn AAPA\, ANCC\, and ACPE credits and/or contact hours by attending this series. It’s the perfect opportunity to expand your knowledge\, connect with peers\, and stay on top of the latest advancements in pulmonary medicine. \nREGISTER FOR FREE.  \n\nFuture sessions include:\n\n\nLos Angeles\, CA – Wednesday\, November 13\, 2025
URL:https://www.pulmapp.com/event/apapp-regional-meeting-series-tampa-fl/
LOCATION:Grand Hyatt Tampa Bay\, 2900 Bayport Dr\, Tampa\, FL\, 33607\, United States
CATEGORIES:Asthma,COPD,Free CME,ILD,Pulmonary Hypertension
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2025/10/FMC-25-31-APAPP-Regional-Conference_Social-Media_Instagram_FL_v6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20251113T120000
DTEND;TZID=America/Chicago:20251113T140000
DTSTAMP:20260406T054958
CREATED:20251029T182555Z
LAST-MODIFIED:20251029T182555Z
UID:18528-1763035200-1763042400@www.pulmapp.com
SUMMARY:A Systematic Approach for Management of Patients With COPD and Alpha1-Antitrypsin Deficiency Presented by: Humam Farah\, MD
DESCRIPTION:Uncover Alpha-1 \nNovember Awareness Month \nYou are invited to: A Systematic Approach for Management of Patients With COPD and Alpha1-Antitrypsin Deficiency \nJoin us to learn about: \n• Alpha-1 Antitrypsin Deficiency (AATD)\n• Ruling out AATD as part of COPD care\n• Systematic screening for AATD and Interpreting test results\n• Managing AATD patients \nPresented by: Humam Farah\, MD\nHosted by: Sophia Robertson-Lavalle Stacy Kinnett \nThursday\, November 13\, 2025 – 12:00PM – Central Standard Time  \n\nVirtual Takeda Location\n650 E Kendall St\nCambridge\, Massachusetts 02142
URL:https://www.pulmapp.com/event/a-systematic-approach-for-management-of-patients-with-copd-and-alpha1-antitrypsin-deficiency-presented-by-humam-farah-md/
CATEGORIES:COPD,Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251113T173000
DTEND;TZID=America/Los_Angeles:20251113T213000
DTSTAMP:20260406T054958
CREATED:20251006T210519Z
LAST-MODIFIED:20251028T153407Z
UID:18423-1763055000-1763069400@www.pulmapp.com
SUMMARY:APAPP Regional Meeting Series: Los Angeles\, CA
DESCRIPTION:Los Angeles\, CA – Join us on Thursday\, November 13\, 2025\, for our sixth and final APAPP Regional Series Session!  \nThis session will be at the Beverly Hills Marriott\, 5:30- 9:15 PM with Brian Bizik\, MS PA-C\, DFAAPA\, and Tyler Kuhk\, MN\, ARNP\, CCRN\, AGNP-C. \nEach regional meeting provides a comprehensive\, guideline-based review of key pulmonary conditions\, including: \n\nInterstitial Lung Disease (ILD)\nChronic Obstructive Pulmonary Disease (COPD)\nAsthma\nPulmonary Hypertension in ILD (PH-ILD)\nObstructive Sleep Apnea (OSA)\n\nOur curriculum is tailored to meet APPs at their current knowledge level\, featuring the latest emerging data and therapeutic updates. We’ll focus on the practical application of evolving evidence to help you provide the best possible care to your patients. \nDon’t miss out on this opportunity to earn credits!  \nYou can earn AAPA\, ANCC\, and ACPE credits and/or contact hours by attending this series. It’s the perfect opportunity to expand your knowledge\, connect with peers\, and stay on top of the latest advancements in pulmonary medicine. \nREGISTER FOR FREE. 
URL:https://www.pulmapp.com/event/apapp-regional-meeting-series-los-angeles-ca/
LOCATION:Beverly Hills Marriott\, 1150 S. Beverly Dr.\, Los Angeles\, CA\, 90035\, United States
CATEGORIES:Asthma,COPD,Free CME,ILD,Pulmonary Hypertension
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2025/10/FMC-25-31-APAPP-Regional-Conference_Social-Media_Twitter_Template_CA_v8.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20251119T120000
DTEND;TZID=America/Denver:20251119T140000
DTSTAMP:20260406T054958
CREATED:20251029T182130Z
LAST-MODIFIED:20251029T182130Z
UID:18527-1763553600-1763560800@www.pulmapp.com
SUMMARY:A Systematic Approach for Management of Patients With COPD and Alpha1-Antitrypsin Deficiency with Brian Bizik
DESCRIPTION:Uncover Alpha-1 \nNovember Awareness Month \nYou are invited to: A Systematic Approach for Management of Patients With COPD and Alpha1-Antitrypsin Deficiency \nJoin us to learn about: \n• Alpha-1 Antitrypsin Deficiency (AATD)\n• Ruling out AATD as part of COPD care\n• Systematic screening for AATD and Interpreting test results\n• Managing AATD patients \nPresented by: Brian Bizik\, MS\,PA\nHosted by: Sophia Robertson-Lavalle  \nWednesday\, November 19\, 2025 – 12:00PM – Mountain Standard Time  \n\nVirtual Takeda Location\n650 E Kendall St\nCambridge\, Massachusetts 02142
URL:https://www.pulmapp.com/event/a-systematic-approach-for-management-of-patients-with-copd-and-alpha1-antitrypsin-deficiency-with-brian-bizik/
LOCATION:Virtual Takeda Location
CATEGORIES:COPD,Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251120T120000
DTEND;TZID=America/New_York:20251120T140000
DTSTAMP:20260406T054958
CREATED:20251029T182918Z
LAST-MODIFIED:20251029T182918Z
UID:18529-1763640000-1763647200@www.pulmapp.com
SUMMARY:A Systematic Approach for Management of Patients With COPD and Alpha1-Antitrypsin Deficiency with Stephen Kovacs
DESCRIPTION:Uncover Alpha-1 \nNovember Awareness Month \nYou are invited to: A Systematic Approach for Management of Patients With COPD and Alpha1-Antitrypsin Deficiency \nJoin us to learn about: \n• Alpha-1 Antitrypsin Deficiency (AATD)\n• Ruling out AATD as part of COPD care\n• Systematic screening for AATD and Interpreting test results\n• Managing AATD patients \nPresented by: Stephen Kovacs\, DO\nHosted by: Sophia Robertson-Lavalle \nThursday\, November 20\, 2025 – 12:00PM – Eastern Standard Time \n\nVirtual Takeda Location\n650 E Kendall St\nCambridge\, Massachusetts 02142
URL:https://www.pulmapp.com/event/a-systematic-approach-for-management-of-patients-with-copd-and-alpha1-antitrypsin-deficiency-with-stephen-kovacs/
LOCATION:Virtual Takeda Location
CATEGORIES:COPD
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260121T190000
DTEND;TZID=America/New_York:20260121T203000
DTSTAMP:20260406T054958
CREATED:20260114T171846Z
LAST-MODIFIED:20260114T171846Z
UID:18791-1769022000-1769027400@www.pulmapp.com
SUMMARY:The Evolving Landscape of Targeted Therapy in Asthma and COPD Care
DESCRIPTION:HRA® offers compensation of $350 to advanced practice providers for your consultative contributions during the event discussions\, responses to polling questions and completion of a post-event survey. \nPlease note: this is a non-CME\, unsponsored program. All content is independently developed by the HCPLive® team.  \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOVERVIEW \nHCPLive® Clinical Forum are regional roundtable discussions where an expert moderator has the opportunity to directly engage with community health care professionals (HCPs) to present data\, medical advances\, and patient case scenarios. This leads to a moderated forum between attendees to gather insights on their community practice implementation of new science\, feedback on case scenarios\, as well as other information which impact the clinical decision making of local HCPs. \nThese forums serve as a platform for localized education and peer-to-peer collaborative discussions aiming to ultimately elevate and improve patient care. \n\n\n\n\n\n\nLEARNING OBJECTIVES \n\nAssess current drivers of treatment escalation in asthma and COPD\, including symptom burden\, exacerbation patterns\, biomarker thresholds\, and guideline recommendations.\nIdentify real-world barriers to timely use of biologic therapies in asthma and COPD and discuss strategies to create greater urgency in care.\nApply clinical trial data and emerging evidence to identify patient populations who might benefit from biologic therapies in asthma and COPD.\n\nModerator: \nSarah Tomashefski\nLead Outpatient Pulmonary Advanced Practice Provider\nPrisma Health\n\n\n\n\n\n\nMARKET RESEARCH PARTICIPATION\n\n\n\n\n\nThis event is held in partnership with Healthcare Research & Analytics (HRA®) to gain market research insights into health care professional’s educational needs in their current practice setting. \nHRA® offers compensation of $350 to advanced practice providers for your consultative contributions during the event discussions\, responses to polling questions and completion of a post-event survey. \nRefer an advanced practice provider for an additional $150 referral bonus courtesy of HCPLive®. Please note both you and your colleague must attend and complete the postevent survey in order to receive the bonus.
URL:https://www.pulmapp.com/event/the-evolving-landscape-of-targeted-therapy-in-asthma-and-copd-care/
LOCATION:Virtual
CATEGORIES:COPD,Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2026/01/HCPLive_Clinical_Forum_ROSBanners_L00-00-0041593.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260205T190000
DTEND;TZID=America/New_York:20260205T200000
DTSTAMP:20260406T054958
CREATED:20260107T230019Z
LAST-MODIFIED:20260107T230019Z
UID:18769-1770318000-1770321600@www.pulmapp.com
SUMMARY:Precision Therapy in COPD—Targeting Type 2 Inflammation
DESCRIPTION:Key Reasons to Attend\n\nLearn about the role that type 2 inflammation plays in COPD and which patients might benefit from biologic therapies\nGet up to speed on the latest clinical evidence on T2i-targeted biologic agents in the treatment of COPD\nHear strategies for creating personalized care plans for your patients\, incorporating an interprofessional care team\n\nAbout ECHO®\n\n\n\n\nProject ECHO®\, developed in 2003 by the University of New Mexico\, is a virtual knowledge-sharing model that connects expert multidisciplinary teams with community-based clinicians\, often from rural or underserved areas\, through regular videoconferencing. Sessions include didactic presentations and learner presented deidentified case-based discussions\, fostering peer-to-peer learning and mentorship. This “all teach\, all learn” approach promotes continuous learning and collaboration\, empowering clinicians to implement best practices and improve healthcare delivery in their communities\, with long-lasting impacts that extend beyond traditional training methods.\n\n\n\nA key component of the COPD ECHO® sessions is the case presentation from learners. We invite you to submit a case for an upcoming discussion during which our expert multidisciplinary faculty and your peers will provide practice feedback you will be able to use to improve care for your patients with COPD. \n*This link will direct you to a HIPAA-compliant website administered by the Boston University Chobanian & Avedisian School of Medicine. \n \n  \nLearn more: https://lrn.peerview.com/150211041_2/150211041_2_p1/stage1reg?CountryID=US&ProjectNumber=150211041_2&MemberID=321989813 \n 
URL:https://www.pulmapp.com/event/precision-therapy-in-copd-targeting-type-2-inflammation/
LOCATION:Virtual
CATEGORIES:COPD,Free CME,Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2026/01/COPD-ECHO-Flyer_PeerView-BU_Page_1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260224T190000
DTEND;TZID=America/New_York:20260224T200000
DTSTAMP:20260406T054958
CREATED:20260107T230432Z
LAST-MODIFIED:20260107T230432Z
UID:18772-1771959600-1771963200@www.pulmapp.com
SUMMARY:An Individualized Approach to Type 2 Inflammation–Driven COPD Care
DESCRIPTION:Key Reasons to Attend\n\nLearn about the role that type 2 inflammation plays in COPD and which patients might benefit from biologic therapies\nGet up to speed on the latest clinical evidence on T2i-targeted biologic agents in the treatment of COPD\nHear strategies for creating personalized care plans for your patients\, incorporating an interprofessional care team\n\nAbout ECHO®\n\n\n\n\nProject ECHO®\, developed in 2003 by the University of New Mexico\, is a virtual knowledge-sharing model that connects expert multidisciplinary teams with community-based clinicians\, often from rural or underserved areas\, through regular videoconferencing. Sessions include didactic presentations and learner presented deidentified case-based discussions\, fostering peer-to-peer learning and mentorship. This “all teach\, all learn” approach promotes continuous learning and collaboration\, empowering clinicians to implement best practices and improve healthcare delivery in their communities\, with long-lasting impacts that extend beyond traditional training methods.\n\n\n\nA key component of the COPD ECHO® sessions is the case presentation from learners. We invite you to submit a case for an upcoming discussion during which our expert multidisciplinary faculty and your peers will provide practice feedback you will be able to use to improve care for your patients with COPD. \n*This link will direct you to a HIPAA-compliant website administered by the Boston University Chobanian & Avedisian School of Medicine. \nCOPD ECHO Flyer_PeerView-BU \n 
URL:https://www.pulmapp.com/event/an-individualized-approach-to-type-2-inflammation-driven-copd-care/
LOCATION:Virtual
CATEGORIES:COPD,Free CME,Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2026/01/COPD-ECHO-Flyer_PeerView-BU_Page_1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260326T190000
DTEND;TZID=America/New_York:20260326T200000
DTSTAMP:20260406T054958
CREATED:20260107T230738Z
LAST-MODIFIED:20260107T230738Z
UID:18775-1774551600-1774555200@www.pulmapp.com
SUMMARY:Selecting the Right Biologic for the Right Person With COPD
DESCRIPTION:Key Reasons to Attend\n\nLearn about the role that type 2 inflammation plays in COPD and which patients might benefit from biologic therapies\nGet up to speed on the latest clinical evidence on T2i-targeted biologic agents in the treatment of COPD\nHear strategies for creating personalized care plans for your patients\, incorporating an interprofessional care team\n\nAbout ECHO®\n\n\n\n\nProject ECHO®\, developed in 2003 by the University of New Mexico\, is a virtual knowledge-sharing model that connects expert multidisciplinary teams with community-based clinicians\, often from rural or underserved areas\, through regular videoconferencing. Sessions include didactic presentations and learner presented deidentified case-based discussions\, fostering peer-to-peer learning and mentorship. This “all teach\, all learn” approach promotes continuous learning and collaboration\, empowering clinicians to implement best practices and improve healthcare delivery in their communities\, with long-lasting impacts that extend beyond traditional training methods.\n\n\n\nA key component of the COPD ECHO® sessions is the case presentation from learners. We invite you to submit a case for an upcoming discussion during which our expert multidisciplinary faculty and your peers will provide practice feedback you will be able to use to improve care for your patients with COPD.\n*This link will direct you to a HIPAA-compliant website administered by the Boston University Chobanian & Avedisian School of Medicine. \nCOPD ECHO Flyer_PeerView-BU
URL:https://www.pulmapp.com/event/selecting-the-right-biologic-for-the-right-person-with-copd/
LOCATION:Virtual
CATEGORIES:COPD,Free CME,Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2026/01/COPD-ECHO-Flyer_PeerView-BU_Page_1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260414T190000
DTEND;TZID=America/New_York:20260414T200000
DTSTAMP:20260406T054958
CREATED:20260107T231351Z
LAST-MODIFIED:20260107T231351Z
UID:18776-1776193200-1776196800@www.pulmapp.com
SUMMARY:Practical Considerations for Targeted Biologic Therapy in COPD
DESCRIPTION:Key Reasons to Attend\n\nLearn about the role that type 2 inflammation plays in COPD and which patients might benefit from biologic therapies\nGet up to speed on the latest clinical evidence on T2i-targeted biologic agents in the treatment of COPD\nHear strategies for creating personalized care plans for your patients\, incorporating an interprofessional care team\n\nAbout ECHO®\n\n\n\n\nProject ECHO®\, developed in 2003 by the University of New Mexico\, is a virtual knowledge-sharing model that connects expert multidisciplinary teams with community-based clinicians\, often from rural or underserved areas\, through regular videoconferencing. Sessions include didactic presentations and learner presented deidentified case-based discussions\, fostering peer-to-peer learning and mentorship. This “all teach\, all learn” approach promotes continuous learning and collaboration\, empowering clinicians to implement best practices and improve healthcare delivery in their communities\, with long-lasting impacts that extend beyond traditional training methods.\n\n\n\nA key component of the COPD ECHO® sessions is the case presentation from learners. We invite you to submit a case for an upcoming discussion during which our expert multidisciplinary faculty and your peers will provide practice feedback you will be able to use to improve care for your patients with COPD.\n*This link will direct you to a HIPAA-compliant website administered by the Boston University Chobanian & Avedisian School of Medicine. \nCOPD ECHO Flyer_PeerView-BU
URL:https://www.pulmapp.com/event/practical-considerations-for-targeted-biologic-therapy-in-copd/
LOCATION:Virtual
CATEGORIES:COPD,Free CME,Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.pulmapp.com/wp-content/uploads/2026/01/COPD-ECHO-Flyer_PeerView-BU_Page_1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260417
DTEND;VALUE=DATE:20260418
DTSTAMP:20260406T054958
CREATED:20251006T220812Z
LAST-MODIFIED:20251217T201706Z
UID:18426-1776384000-1776470399@www.pulmapp.com
SUMMARY:Cleveland Citywide COPD Summit 2026
DESCRIPTION:COPD care continues to rely on traditional GOLD staging and inhaler-based approaches\, yet patients present with diverse phenotypes and high burden of extrapulmonary complications. This educational activity will personalize COPD management and improve patient-centered outcomes across disciplines. \nBy Participating\, You Will Be Able To:\n\nRecognize COPD phenotypes beyond GOLD staging.\nAssess environmental and behavioral factors influencing COPD outcomes.\nApply evidence-based inhaler therapy and adherence strategies.\nEvaluate emerging biologic therapies for COPD.\nIncorporate advanced therapies for COPD (lung volume reduction\, noninvasive ventilation)\nUtilize interprofessional models to improve patient-centered care.\n\nWho Should Attend?\nThis activity is designed for physicians\, pharmacists\, social workers\, therapists\, nurses\, nurse practitioners\, residents\, fellows and other professionals interested in critical care\, internal medicine\, nursing and pulmonology. \n  \nRegister Here: https://www.clevelandclinicmeded.com/live/courses/copd/
URL:https://www.pulmapp.com/event/cleveland-citywide-copd-summit-2026/
LOCATION:Cleveland Clinic Beachwood Administrative Campus\, 25875 Science Park Drive\, Beachwood\, OH\, 44122\, United States
CATEGORIES:COPD
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2025/10/image-11.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260618
DTEND;VALUE=DATE:20260621
DTSTAMP:20260406T054958
CREATED:20251013T231851Z
LAST-MODIFIED:20251013T231851Z
UID:18460-1781740800-1781999999@www.pulmapp.com
SUMMARY:3rd Annual APAPP National Conference
DESCRIPTION:We are so excited to announce that the 3rd Annual APAPP National Conference will be held June 18-20\, 2026\, at the Red Rock Casino Resort & Spa in Las Vegas. \nJoin 500+ APPs for 3 powerhouse days of education\, networking\, and hands-on learning. Dive into expert-led sessions designed by APPs\, for APPs. Sharpen your skills in interactive workshops. Connect with peers from across the country.Topics include sleep disorders\, ILDs\, COPD\, pulmonary hypertension\, asthma\, interventional pulmonology\, chronic symptoms\, and professional development.Don’t miss the premier event shaping the future of pulmonary\, critical care\, and sleep medicine. Registration opens soon. Find more event details here.  \nThis year\, we’ll have 45-minute Breakout Sessions dedicated to member submissions. If you’re interested in presenting\, please fill out THIS FORM. Submission due Monday\, November 3rd\, 2025.
URL:https://www.pulmapp.com/event/3rd-annual-apapp-national-conference/
LOCATION:Red Rock Casino Resort & Spa\, 11011 W Charleston Blvd\, Las Vegas\, NV\, 89135\, United States
CATEGORIES:Asthma,COPD,Critical Care,ILD,Pulmonary Hypertension,Sleep
ATTACH;FMTTYPE=image/png:https://www.pulmapp.com/wp-content/uploads/2025/10/APAPP2026-SavetheDate.png
END:VEVENT
END:VCALENDAR